Dialectical Behavior Therapy for Adolescents With Fetal Alcohol Spectrum Disorders Feasibility Trial
NCT ID: NCT06747650
Last Updated: 2026-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2024-12-24
2025-10-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dialectical Behavioral Therapy in Juvenile Justice
NCT05583279
Fostering Healthy Futures Efficacy Trial for Preadolescent Youth in Foster Care
NCT00810056
Dialectical Behavior Therapy for Adolescents With Self-harm and Suicidal Behavior- an Open Trial
NCT06315075
Intervention Development and Pilot for Foster Care Youth
NCT00809315
Preventing Behavior and Health Problems in Foster Teens
NCT01549561
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active DBT-A Intervention Arm
A single cohort of teens with FASD will be administered DBT-A for the purpose of feasibility testing.
Dialectical Behavior Therapy for Adolescents
Standard of care (SOC) DBT-A includes approximately six weeks of pretreatment, and approximately six months of DBT-A skills group, individual therapy, and 24/7 phone coaching. During pre-treatment, clients are oriented to the DBT-A model and client commitment to treatment is established. After approximately six weeks, the client enters DBT-A skills group along with their caregiver. This skills group meets weekly for 1.5 hours and clinicians explain the five main DBT-A skills (mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness, and walking the middle path) via PowerPoints and discussion. Clients and their caregivers are assigned weekly homework. At the same time, teens are completing weekly 1-hour individual therapy sessions where they are utilizing the skills learned in group. Both teens and caregivers have access to what DBT-A calls 24/7 phone coaching. This phone coaching is 24/7 access to a therapist when a crisis is arising.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dialectical Behavior Therapy for Adolescents
Standard of care (SOC) DBT-A includes approximately six weeks of pretreatment, and approximately six months of DBT-A skills group, individual therapy, and 24/7 phone coaching. During pre-treatment, clients are oriented to the DBT-A model and client commitment to treatment is established. After approximately six weeks, the client enters DBT-A skills group along with their caregiver. This skills group meets weekly for 1.5 hours and clinicians explain the five main DBT-A skills (mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness, and walking the middle path) via PowerPoints and discussion. Clients and their caregivers are assigned weekly homework. At the same time, teens are completing weekly 1-hour individual therapy sessions where they are utilizing the skills learned in group. Both teens and caregivers have access to what DBT-A calls 24/7 phone coaching. This phone coaching is 24/7 access to a therapist when a crisis is arising.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 14-17 years
* Have a diagnosis of FASD under any diagnostic criteria
* Residing in the state of New York
* Willing and able to attend group sessions virtually
* Have one of the following:
1. A diagnosis of disruptive mood dysregulation disorder, borderline personality disorder, or multiple other serious mental health diagnoses
2. A history of multiple psychiatric hospitalizations and/or recurring presentation at psychiatric emergency rooms
3. A score of 7+ on the McLean screening instrument (MSI; instrument attached and included in eligibility screen)
* Have functional deficits in three of five problem areas:
1. Emotional dysregulation
2. Impulsivity (including avoidance)
3. Interpersonal challenges
4. Teenager and family challenges
5. Reduced awareness and focus
* Access to the internet and device with Zoom capabilities
For caregivers:
* Parent or legal guardian of an adolescent (ages 14-17 years) with an FASD diagnosis
* Residing in the state of New York
* Willing and able to attend group sessions virtually
* Access to the internet and device with Zoom capabilities
For clinicians:
* Employee of GVP
* Administered DBT-A to teens with FASD as part of this study
Exclusion Criteria
* Primary psychotic disorder
* Ongoing substance/drug dependence or eating disorder at such a level that would impede engagement with DBT modalities (i.e. if an individual requires detoxification or hospitalization for stabilization)
* Adolescent or caregiver has a moderate to severe intellectual disability (IQ \< 51)
14 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christie Petrenko
Research Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rochester Medical Center
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00009819
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.